Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
238 participants
INTERVENTIONAL
2016-09-01
2018-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Aim: This study from the University of Hong Kong aims to determine the characteristics of a sustainable approach to setting up an effective and quality-controlled screening service for DR in the private primary care sector of Hong Kong and to estimate the potential benefit to be gained in terms of impact on avoidable vision loss, costs of care and potential for further development of this model in chronic disease care.
Methods:A screening centre is being set up and a randomised study carried out in which screening will be offered at three different fee levels to subjects recruited by their general practitioner (GP). The following data will be collected (a) willingness to attend screening at the different fee levels (b) screening findings in terms of DR and other eye diseases (c) risk factors and other characteristics of those screened and unscreened. The information will allow us to estimate the level of fee which best combines effectiveness with sustainability in the longer term.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Cost-effectiveness of Screening for Diabetic Retinopathy in Hong Kong
NCT01628289
AI-Powered DIY Screening System for Diabetic Retinopathy
NCT06892353
Evaluation System and Clinical Application for Diabetic Retinopathy
NCT03528720
Analysis of Risk Factors of Diabetic Retinopathy
NCT06154746
Real-world Diagnostic Effectiveness of Artificial Intelligence Algorithm in Diabetic Retinopathy Screening
NCT03911323
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Free screening group
Subjects in this group receive free diabetic retinopathy screening.
Free screening group
The intervention provide Diabetic Retinopathy screening without charging a fee.
Pay screening group ($150)
Subjects in this group receiving diabetic retinopathy screening will be charged HK$150.
Pay screening group ($150)
The intervention is charging HK$150 for the Diabetic Retinopathy screening.
Pay screening group ($300)
Subjects in this group receiving diabetic retinopathy screening will be charged HK$300.
Pay screening group ($300)
The intervention is charging HK$300 for the Diabetic Retinopathy screening.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Free screening group
The intervention provide Diabetic Retinopathy screening without charging a fee.
Pay screening group ($150)
The intervention is charging HK$150 for the Diabetic Retinopathy screening.
Pay screening group ($300)
The intervention is charging HK$300 for the Diabetic Retinopathy screening.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to give informed consent
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jonathan Cheuk Hung Chan, MBBS
Role: PRINCIPAL_INVESTIGATOR
The University of Hong Kong
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Ophthalmology, The University of Hong Kong, Hong Kong
Hong Kong, , Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12133951
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.